Skip to content

Author

S. Yoshioka

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

TL1A-DR3 Signaling in Inflammatory Bowel Disease: From Pathogenesis to Therapeutic Targeting.

Current evidence highlights TL1A blockade as a promising dual-pathway therapeutic approach targeting inflammation and fibrotic remodeling, with ongoing studies expected to define its long-term impact on disease modification.

Kozo Tsuruta, Shinichiro Yoshioka, Hidetoshi Takedatsu · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.